Aneri Pattani Data visualizations by Lydia Zuraw December 16, 2024 In the past few years, state and local governments across the U.S. have begun spending ...

This article first appeared on KFF Health News. To view the data, see the original article on the site. In the last few years ...

Vertex Pharmaceuticals (NASDAQ: VRTX) fell by 13% on Dec. 19, when the rare-disease drug developer reported some lackluster ...

In the past few years, state and local governments across the U.S. have begun spending billions in opioid settlements paid by ...

We recently compiled a list of the Jim Cramer Talked About These 17 Stocks After The Fed’s Rate Cut. In this article, we are ...

Vertex Pharmaceuticals Inc. notched two FDA victories late Friday for its cystic fibrosis medicines, increasing the number of ...

Painkillers are a common part of life for many people. From headaches to muscle pain, they offer quick relief. But if you ...

The Boston drugmaker announced the results of a mid-stage trial of its non-opioid painkiller on Thursday — and its shares ...

From addiction treatment to toy robot ambulances, here's how state and local governments used billions in opioid settlement ...

We recently compiled a list of the 6 Stocks Jim Cramer Talked About This Week. In this article, we are going to take a look ...

Vertex Pharma's non-opioid painkiller suzetrigine was unable to perform better than placebo in a phase 2 trial in lumbar ...

Vertex Pharmaceuticals (VRTX) is plummeting after disappointing trial results, headed for its worst day in four years ...